This preclinical study demonstrated that IA is beneficial for COPD treatment, likely by increasing the anti-oxidative capacity and inhibiting Smad2/3 activation in lung tissue.
Share your take
Add a clinician perspective alongside expert commentary.
Li et al. (Fri,) studied this question.